rapid
accur
diagnost
test
essenti
control
ongo
pandem
current
gold
standard
diagnosi
realtim
rtpcr
detect
nasopharyng
swab
low
sensit
exposur
risk
healthcar
worker
global
shortag
swab
person
protect
equip
howev
necessit
valid
new
diagnost
approach
saliva
promis
candid
diagnost
collect
minim
invas
reliabl
selfadminist
saliva
exhibit
compar
sensit
nasopharyng
swab
detect
respiratori
pathogen
includ
endem
human
coronavirus
previou
studi
valid
use
saliva
detect
test
nasopharyng
saliva
sampl
confirm
patient
selfcollect
sampl
healthcar
worker
ward
compar
detect
patientmatch
nasopharyng
saliva
sampl
found
saliva
yield
greater
detect
sensit
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
medrxiv
preprint
consist
throughout
cours
infect
furthermor
report
less
variabl
selfsampl
collect
saliva
taken
togeth
find
demonstr
saliva
viabl
sensit
altern
nasopharyng
swab
could
enabl
athom
selfadminist
sampl
collect
accur
largescal
test
effort
control
novel
coronaviru
caus
pandem
depend
accur
rapid
diagnost
test
test
must
sensit
mild
asymptomat
infect
promot
effect
self
isol
reduc
transmiss
within
high
risk
group
consist
reliabl
monitor
diseas
progress
aid
clinic
decis
scalabl
inform
local
nation
public
health
polici
social
distanc
measur
safe
relax
howev
current
test
strategi
often
fail
meet
criteria
part
relianc
nasopharyng
swab
wide
recommend
sampl
type
realtim
rtpcr
although
nasopharyng
swab
commonli
use
respiratori
viru
diagnost
show
rel
poor
sensit
detect
earli
infect
inconsist
serial
test
moreov
collect
nasopharyng
swab
caus
discomfort
patient
due
procedur
invas
limit
complianc
repeat
test
present
consider
risk
healthcar
worker
induc
patient
sneez
cough
expel
viru
particl
procedur
also
conduc
largescal
test
widespread
shortag
swab
person
protect
equip
healthcar
worker
selfcollect
nasopharyng
swab
difficult
less
sensit
viru
detect
challeng
exacerb
pandem
intensifi
low
incom
countri
given
limit
reliabl
less
resourceintens
sampl
collect
method
ideal
one
accommod
selfcollect
home
urgent
need
saliva
sampl
appeal
altern
nasopharyng
swab
sinc
collect
saliva
noninvas
easi
selfadminist
analysi
nasopharyng
saliva
concord
rtpcr
detect
respiratori
pathogen
includ
two
season
human
coronavirus
suggest
compar
diagnost
sensit
two
sampl
type
preliminari
find
indic
detect
saliva
patient
selfcollect
saliva
sampl
compar
detect
sensit
nasopharyng
swab
collect
healthcar
worker
mild
subclin
case
critic
howev
rigor
evalu
sensit
detect
saliva
respect
nasopharyng
swab
conduct
inpati
cours
infect
studi
evalu
detect
pair
nasopharyng
swab
saliva
sampl
collect
inpati
asymptomat
healthcar
worker
moderatetohigh
risk
exposur
result
indic
use
saliva
detect
sensit
consist
use
nasopharyng
swab
overal
demonstr
saliva
consid
reliabl
sampl
type
allevi
test
demand
determin
saliva
perform
well
us
cdc
recommend
use
nasopharyng
swab
diagnost
collect
clinic
sampl
inpati
studi
particip
tabl
cohort
repres
rang
patient
sever
diseas
requir
intens
care
requir
mechan
ventil
deceas
april
use
us
cdc
rtpcr
assay
test
selfcollect
saliva
healthcar
workeradminist
nasopharyng
swab
cohort
found
strong
concord
us
cdc
primerprob
set
extend
data
fig
thu
calcul
viru
titer
viru
copiesml
use
set
posit
sampl
test
n
nasopharyng
saliva
found
geometr
mean
viru
titer
saliva
higher
nasopharyng
swab
p
mannwhitney
test
fig
limit
analysi
patientmatch
nasopharyng
saliva
sampl
n
sampl
type
found
titer
saliva
significantli
higher
nasopharyng
swab
p
wilcoxon
test
fig
moreov
detect
saliva
nasopharyng
swab
eight
match
sampl
detect
nasopharyng
swab
saliva
three
match
sampl
fig
overal
found
higher
titer
saliva
nasopharyng
swab
hospit
inpati
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
fig
show
correl
us
cdc
assay
result
tempor
diagnost
test
nasopharyng
swab
report
variabl
test
longitudin
nasopharyng
saliva
sampl
inpati
determin
sampl
type
provid
consist
result
particip
multipl
nasopharyng
swab
particip
multipl
saliva
sampl
found
titer
gener
decreas
sampl
type
follow
report
date
symptom
onset
fig
nasopharyng
swab
result
consist
previou
report
variabl
titer
result
found
instanc
particip
nasopharyng
swab
neg
follow
posit
result
next
collect
repeat
fig
longitudin
saliva
collect
patient
howev
instanc
sampl
test
neg
later
follow
posit
result
true
neg
test
result
import
clinician
track
patient
improv
decis
regard
discharg
data
suggest
saliva
consist
sampl
type
nasopharyng
swab
monitor
tempor
chang
titer
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
longitudin
titer
saliva
nasopharyng
swab
shown
day
sinc
symptom
onset
circl
repres
separ
sampl
connect
addit
sampl
patient
dash
line
assay
detect
limit
use
us
cdc
assay
cycl
threshold
correspond
viru
copiesml
sampl
shown
dot
line
grey
area
b
data
also
shown
sampl
moment
sequenti
collect
time
highlight
differ
viru
titer
collect
point
data
use
gener
figur
includ
raw
cycl
threshold
found
supplementari
data
valid
saliva
detect
subclin
infect
could
prove
transform
remot
patient
diagnost
healthcar
worker
surveil
investig
enrol
asymptomat
healthcar
worker
studi
collect
saliva
andor
nasopharyng
swab
averag
everi
day
rang
day
tabl
date
detect
saliva
two
healthcar
worker
neg
nasopharyng
swab
use
us
cdc
test
report
symptom
saliva
one
individu
test
posit
alongsid
match
neg
nasopharyng
swab
upon
repeat
test
day
later
viru
titer
asymptomat
healthcar
worker
saliva
lower
typic
detect
symptomat
inpati
fig
like
support
lack
symptom
limit
data
support
saliva
may
sensit
detect
asymptomat
presymptomat
infect
howev
larger
sampl
size
need
confirm
nasopharyng
swab
sampl
inconsist
may
one
potenti
issu
fals
neg
fig
monitor
intern
control
proper
sampl
collect
human
rnase
p
may
provid
altern
evalu
techniqu
human
rnase
p
detect
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
better
saliva
inpati
healthcar
worker
cohort
fig
alon
may
indic
better
viru
detect
importantli
found
human
rnase
p
detect
variabl
nasopharyng
swab
collect
inpati
p
f
test
varianc
selfcollect
healthcar
worker
p
fig
result
suggest
saliva
may
also
appropri
perhap
sensit
altern
nasopharyng
swab
screen
asymptomat
presymptomat
infect
studi
demonstr
saliva
viabl
prefer
altern
nasopharyng
swab
detect
found
sensit
detect
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
saliva
compar
superior
nasopharyng
swab
earli
hospit
consist
extend
hospit
recoveri
moreov
detect
saliva
two
asymptomat
healthcar
worker
despit
neg
match
nasopharyng
swab
suggest
saliva
may
also
viabl
altern
identifi
mild
subclin
infect
valid
widespread
implement
saliva
sampl
could
transform
public
health
effort
saliva
selfcollect
negat
need
direct
healthcar
workerpati
interact
sourc
sever
major
test
bottleneck
overal
nosocomi
infect
risk
allevi
suppli
demand
swab
person
protect
equip
viral
load
differ
mild
sever
case
limit
studi
primari
focu
inpati
mani
sever
diseas
data
requir
rigor
compar
efficaci
saliva
hospit
set
earlier
cours
infect
find
two
recent
studi
support
potenti
detect
asymptomat
individu
outpati
infecti
viru
detect
saliva
patient
ascertain
relationship
viru
genom
copi
infecti
viru
particl
saliva
presymptomat
individu
play
key
role
understand
dynam
asymptomat
transmiss
stem
promis
result
detect
asymptomat
individu
saliva
detect
assay
alreadi
gain
approv
us
food
drug
administr
emerg
use
author
meet
grow
test
demand
howev
find
support
need
immedi
valid
implement
saliva
diagnost
certifi
clinic
laboratori
studi
particip
enrol
sampl
accord
yale
univers
hicapprov
protocol
demograph
clinic
data
sampl
collect
studi
particip
acknowledg
understood
studi
protocol
sign
inform
consent
particip
inform
sampl
collect
associ
studi
identifi
inpati
patient
admit
yale
new
hospit
tertiari
care
medic
center
new
ct
usa
test
posit
nasopharyng
andor
oropharyng
swab
cdc
approv
assay
invit
enrol
research
studi
exclus
criteria
age
year
nonenglish
speak
clinic
radiolog
laboratori
evid
noninfecti
caus
fever
respiratori
symptom
microbiologicallyconfirm
infecti
sourc
eg
gastrointestin
urinari
cardiovascular
respiratori
tract
symptom
suspicion
infect
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
asymptomat
healthcar
worker
eg
without
fever
respiratori
symptom
occup
exposur
patient
invit
enrol
studi
studi
particip
enabl
activ
surveil
ensur
earli
detect
follow
exposur
protect
healthcar
worker
patient
inpati
nasopharyng
saliva
sampl
obtain
everi
three
day
throughout
clinic
cours
nasopharyng
sampl
taken
regist
nurs
use
bd
univers
viral
transport
uvt
system
flexibl
minitip
swab
pass
patient
nostril
posterior
nasopharynx
reach
left
place
sever
second
absorb
secret
slowli
remov
rotat
swab
place
steril
viral
transport
media
total
volum
ml
seal
secur
saliva
sampl
selfcollect
patient
upon
wake
patient
ask
avoid
food
water
brush
teeth
sampl
collect
patient
ask
repeatedli
spit
steril
urin
cup
roughli
third
full
liquid
exclud
bubbl
secur
close
sampl
store
room
temperatur
transport
research
lab
yale
school
public
health
within
hour
sampl
collect
healthcar
worker
healthcar
worker
ask
collect
selfadminist
nasopharyng
swab
saliva
sampl
everi
three
day
period
week
sampl
store
transport
research
lab
arriv
research
lab
total
nucleic
acid
extract
viral
transport
media
nasopharyng
swab
whole
saliva
use
magmax
viralpathogen
nucleic
acid
isol
kit
thermofish
scientif
follow
manufactur
protocol
elut
elut
buffer
rna
detect
rna
templat
test
previous
describ
use
us
cdc
realtim
rtpcr
primerprob
set
human
rnase
p
rp
extract
control
sampl
classifi
posit
primerprob
set
detect
c
viru
copi
quantifi
use
dilut
standard
curv
rna
transcript
previous
gener
result
compar
extend
data
fig
viru
copi
shown
calcul
use
primerprob
set
statist
analys
conduct
graphpad
prism
describ
result
dedic
work
made
studi
possibl
also
thank
taylor
p
jack
technic
discuss
studi
partial
fund
yale
institut
global
health
correspond
author
full
access
data
studi
final
respons
decis
submit
public
extend
data
fig
concord
detect
use
us
cdc
primer
probe
set
ct
rtpcr
cycl
threshold
dot
line
grey
area
indic
limit
detect
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
